5.39

5.39 (-0.58%)

As of Feb 16, 2022

SAB Biotherapeutics, Inc. [SABS]

Source: 

Company Overview

Sab Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of proprietary immunotherapeutic fully-human antibodies, or fully-human immunoglobulins, to treat and prevent immune and autoimmune disorders as well as infectious diseases that have significant mortality and health impacts on high-risk patients.

CountryUS
Headquarterssioux fallssouth dakota
Phone Number(605) 679-6980
Industry
CEOEddie J. Sullivan
Websitewww.sab.bio

Recent Stories